INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9
Management to host conference call and webcast at 4:30 pm ET on that day
Boca Raton, Florida, May 07, 2024 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ:INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced that it will host a conference call on Thursday, May 9, 2024, at 4:30 PM EDT to discuss results for its first quarter ended March 31, 2024 and to provide a corporate update.